Evidence map›Paper›PMID 32884962›Full record

ArticleEye and vision (London, England)2020

Automated diagnosis and staging of Fuchs' endothelial cell corneal dystrophy using deep learning.

Taher Eleiwa, Amr Elsawy, Eyüp Özcan, Mohamed Abou Shousha

Open access · diamondAbstract read
In one paragraph

Article in Eye and vision (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. A Review of the Use of Artificial Intelligence in Ophthalmology Imaging: Approximation to Ocular Histopathology.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Artificial intelligence in corneal diseases: A narrative review.Contact lens & anterior eye : the journal of the British Contact Lens Association · 2024
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Role of artificial intelligence in cornea practice.Indian journal of ophthalmology · 2024
    Article
  17. Artificial intelligence-assisted diagnosis of ocular surface diseases.Frontiers in cell and developmental biology · 2023
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 3 countries.

Taher EleiwaBascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, Florida 33136 USA.
Amr ElsawyBascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, Florida 33136 USA.
Eyüp ÖzcanBascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, Florida 33136 USA.
Mohamed Abou ShoushaBascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, Florida 33136 USA.ORCID 0000-0002-4508-0492
University of Miami · US

Funding

Shared Equipment ModuleP30EY014801 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Victor L Perez · 2004 to 2026
$12.2M
Endothelium/Descemet's membrane Complex Optical TomographyK23EY026118 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ABOU SHOUSHA, MOHAMED FADEL · 2016 to 2020
$1.1M
NEI NIH HHS K23 EY026118NEI NIH HHS P30 EY014801
6 · The paper itself

Abstract

backgroundTo describe the diagnostic performance of a deep learning algorithm in discriminating early-stage Fuchs' endothelial corneal dystrophy (FECD) without clinically evident corneal edema from healthy and late-stage FECD eyes using high-definition optical coherence tomography (HD-OCT).

methodsIn this observational case-control study, 104 eyes (53 FECD eyes and 51 healthy controls) received HD-OCT imaging (Envisu R2210, Bioptigen, Buffalo Grove, IL, USA) using a 6 mm radial scan pattern centered on the corneal vertex. FECD was clinically categorized into early (without corneal edema) and late-stage (with corneal edema). A total of 18,720 anterior segment optical coherence tomography (AS-OCT) images (9180 healthy; 5400 early-stage FECD; 4140 late-stage FECD) of 104 eyes (81 patients) were used to develop and validate a deep learning classification network to differentiate early-stage FECD eyes from healthy eyes and those with clinical edema. Using 5-fold cross-validation on the dataset containing 11,340 OCT images (63 eyes), the network was trained with 80% of these images (3420 healthy; 3060 early-stage FECD; 2700 late-stage FECD), then tested with 20% (720 healthy; 720 early-stage FECD; 720 late-stage FECD). Thereafter, a final model was trained with the entire dataset consisting the 11,340 images and validated with a remaining 7380 images of unseen AS-OCT scans of 41 eyes (5040 healthy; 1620 early-stage FECD 720 late-stage FECD). Visualization of learned features was done, and area under curve (AUC), specificity, and sensitivity of the prediction outputs for healthy, early and late-stage FECD were computed.

resultsThe final model achieved an AUC of 0.997 ± 0.005 with 91% sensitivity and 97% specificity in detecting early-FECD; an AUC of 0.974 ± 0.005 with a specificity of 92% and a sensitivity up to 100% in detecting late-stage FECD; and an AUC of 0.998 ± 0.001 with a specificity 98% and a sensitivity of 99% in discriminating healthy corneas from all FECD.

conclusionDeep learning algorithm is an accurate autonomous novel diagnostic tool of FECD with very high sensitivity and specificity that can be used to grade FECD severity with high accuracy.

Indexed as

Corneal endotheliumDescemet’s membraneFuchs endothelial dystrophyOptical coherence tomography

Identifiers

PMID32884962
PMCPMC7460770
OpenAlexW3082413267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.